iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome-Reference-Cited by-同舟云学术

iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome

Published:2021-10 Issue:10 Volume:16 Page:2488-2502
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Kosanke Maike,Davenport Colin,Szepes Monika,Wiehlmann Lutz,Kohrn Tim,Dorda Marie,Gruber Jonas,Menge Kaja,Sievert Maike,Melchert Anna,Gruh Ina,Göhring Gudrun,Martin Ulrich

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference49 articles.

1. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update;Afgan;Nucleic Acids Res.,2018

2. Assessing the safety of human pluripotent stem cells and their derivatives for clinical applications;Andrews;Stem Cell Reports,2017

3. Mitochondrial network state scales mtDNA genetic dynamics;Aryaman;Genetics,2019

4. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles;Bonora;Nat. Rev. Cardiol.,2019

5. New evidence confirms that the mitochondrial bottleneck is generated without reduction of mitochondrial DNA content in early primordial germ cells of mice;Cao;PLoS Genet.,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives;Biochemistry (Moscow);2024-05

2. Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity;Progress in Retinal and Eye Research;2024-05

3. Metabolic control of induced pluripotency;Frontiers in Cell and Developmental Biology;2024-01-11

4. Association of Inflammatory Mediators with Mitochondrial DNA Variants in Geriatric COVID-19 Patients;aging and disease;2024

5. Targeting mitochondria in dermatological therapy: beyond oxidative damage and skin aging;Expert Opinion on Therapeutic Targets;2022-03-04